Ketamine / KAPPending re-verificationPrivate-market model

BKH Bayreuth

Bayreuth, Germany

Treatment & access

  • Treatments offeredKetamine treatment (intravenous infusion and nasal spray) · Electroconvulsive therapy (ECT), including outpatient maintenance ECT · Repetitive transcranial magnetic stimulation (rTMS), inpatient or outpatient after specialist referral · Vagus nerve stimulation (VNS) · Light therapy and wake therapy · Individual and group psychotherapy (psychodynamic, behavioural, mindfulness-based) · Ergotherapy, music therapy, body/exercise therapy, relaxation therapy, acupuncture · Social skills training and sociopedagogical counselling
  • Access routeprivate_pay
  • Price informationPrices are not published on the provider's website. Treatment is hospital-based at a public district hospital; admission to the depression programme follows referral (Einweisung) by an office-based physician, and registration for ketamine treatment must be submitted via the treating physician using the hospital's registration form.
  • Phone+49 921 283-2153
  • Websitehttps://gebo-med.de

About this provider

Bezirkskrankenhaus Bayreuth is a public psychiatric hospital of the Gesundheitseinrichtungen des Bezirks Oberfranken (GeBO). Its Center for Neurostimulation and Ketamine Treatment provides ketamine therapy — by infusion or nasal spray — for treatment-resistant depression alongside electroconvulsive therapy, repetitive transcranial magnetic stimulation and vagus nerve stimulation, some services also on an outpatient basis. The affiliated Depressionszentrum Bayreuth (wards A1 and A5), repeatedly awarded the Focus seal 'Top National Hospital Depression', offers full and partial inpatient multimodal treatment with an average stay of around 50 days. Ketamine treatment is generally delivered under full inpatient conditions, requires prior written registration through a treating physician, and is primarily offered to patients from the Bayreuth and Kulmbach catchment area.

Services & programs

  • Ketamine therapyFor treatment-resistant depression, given as an infusion or nasal spray at doses that cause only mild drowsiness rather than anaesthesia. Initially administered twice per week over several weeks because the effect of a single treatment lasts only a few days; per the hospital, ketamine often works within 24 hours and — like ECT — also acts specifically against suicidal thoughts and impulses. Treatment is generally under full inpatient conditions. Not published
  • Electroconvulsive therapy (ECT)For therapy-resistant depression and psychotic illness, performed under anaesthesia with muscle relaxation; usually ten to fifteen inpatient sessions, with first effects after three to four treatments; outpatient maintenance ECT over months is possible in some cases. Not published
  • Repetitive transcranial magnetic stimulation (rTMS) and vagus nerve stimulation (VNS)rTMS as a supportive treatment for depressive disorders, inpatient or outpatient after specialist referral. VNS for depression with poor response to other therapies; the stimulator is implanted at a neurosurgical clinic and adjusted in several outpatient appointments at the Bayreuth stimulation center. Not published
  • Depression Center inpatient and day-clinic treatmentMultimodal treatment on specialized wards A1 and A5 for unipolar and bipolar depression, adjustment and stress reactions, depression in physical illness and postpartum depression (mother-and-child treatment possible), combining biological treatments with individual and group psychotherapy, ergotherapy, music therapy, exercise therapy, relaxation, acupuncture and psychoeducation, embedded in primary nursing. Not published

Programs & studies

ProgramKindStatus
Center for Neurostimulation and Ketamine Treatment
Registration exclusively via written form (dedicated ketamine registration PDF) completed together with a treating office-based physician, plus a current physician's letter with organic exclusion diagnostics, sent by mail, fax or post; incomplete registrations are not processed. Direct patient contact is discouraged.
ketamine_and_neurostimulationactive
Depressionszentrum Bayreuth (wards A1 and A5)
Average treatment duration around 50 days; day-clinic (partial inpatient) treatment possible, usually following the inpatient phase; hospital repeatedly awarded the Focus seal 'Top National Hospital Depression'.
inpatient_day_clinicactive
Regional catchment service
Treatments are offered primarily to patients within the service area (city of Bayreuth, districts of Bayreuth and Kulmbach); the hospital states it generally cannot offer outpatient or inpatient ketamine/neurostimulation treatment to patients from distant places.
access_policyactive

Pricing

ItemPrice
Ketamine treatment / neurostimulation / depression ward stay
Public district hospital; admission follows physician referral and no self-pay price list is published on the website.
Not published

Prices are taken from the provider's own website and were last checked on . Always confirm the current price with the provider before booking.

Facilities & languages

  • Facilities
    • Dedicated Center for Neurostimulation and Ketamine Treatment (Nordring 2, 95445 Bayreuth)
    • Two specialized depression wards (A1 and A5) with mother-and-child treatment places for postpartum depression
    • Day clinics for adults and a psychiatric outpatient department (Institutsambulanz) in Bayreuth
    • ECT, rTMS and VNS equipment on site
  • LanguagesWebsite in German; the site additionally offers a plain-language German section (Einfache Sprache).
  • TeamThe Neurostimulation Center is led by Dr. med. Johannes Kornacher (leading senior physician); Dr. med. Stephanie Tieden is leading senior physician of the Depression Center and Neurostimulation Center. The therapeutic team includes physicians, psychological psychotherapists and psychologists, social pedagogues, ergotherapists, a music therapist, an exercise therapist and specialist nursing staff experienced in depression care.

Common questions

How do I get a ketamine treatment appointment?

Not by contacting the hospital directly. Patients must first see an office-based physician, complete the hospital's ketamine registration form together with that physician, and send it with a current, informative physician's letter (including organic exclusion diagnostics) to the center's secretariat by email, fax or post. Whether the offered therapies are suitable must be clarified in advance with the treating outpatient physicians, and incomplete registrations are not processed.

Can I be treated if I live far from Bayreuth?

Generally no. The hospital offers these treatments primarily to patients within its service area — the city of Bayreuth and the districts of Bayreuth and Kulmbach — and states that treating patients from distant places is usually not feasible logistically or sensible therapeutically.

Is ketamine treatment inpatient or outpatient?

Ketamine treatment is generally carried out under full inpatient conditions. Some neurostimulation services (e.g. maintenance ECT, rTMS after specialist referral) are also available on an outpatient basis, and day-clinic depression treatment is possible, usually after an inpatient phase.

What does the ketamine treatment involve?

Ketamine is given by infusion or nasal spray at a dose causing only mild drowsiness. Because the effect of a single treatment lasts only a few days, it is initially given twice weekly over several weeks; it often works within 24 hours. Transient dream-like shifts of consciousness or a feeling of intoxication can occur during administration. The hospital emphasizes that lasting benefit requires accompanying psychotherapy.

What about costs and insurance?

The website does not publish prices. Care is provided as public hospital treatment following referral (Einweisung) by an office-based physician; cost questions are handled through the referral and admission process.

Looking at alternatives? For patients outside the catchment area, esketamine nasal spray for treatment-resistant depression is available at qualified psychiatric hospitals and practices across Germany with statutory coverage; other legal routes include university-hospital ketamine programmes, clinical trials, and compassionate-use psilocybin in narrowly defined individual cases.

Verification

This record was verified previously and is awaiting its scheduled re-check against the registry.

  • License / registryPublic trial registry (ClinicalTrials.gov / EU CTIS)
  • Sourcehttps://gebo-med.de
  • Last verified

Spotted an error? See our methodology for how records are checked and how to report a correction.